ARCHIVES

Golde To Step Down At MSK; Porter Joins Hogan & Hartson.

This article is from The Cancer Letter archive.

Vol. 27 No. 04 | January 26, 2001

Download PDF Visit The Full Archive

Related Articles

In Phase II Study, Vaccine IMA910 Stimulated Immune Response

February 24, 2012

FDA Approves Erbitux for Head & Neck Cancer.

March 3, 2006

Gregory Reaman Elected Chairman, C.O.G.; NCI Seeks Nominations For Consumer Group. “We Need A Long-Term Commitment” To Discovery.

December 15, 2000

CCIRC Okays New Effort To Rate Disease Committees, Modalities In Groups, Effective with Next Round

November 20, 1981

NIH To Give 3 Percent Increase to Grants

March 20, 2009

NCI Preliminary Budge For 1979 By Mechanism

June 3, 1977